Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Nervecentre
HQ United Kingdom · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Nov 2025: Nottingham University Hospitals declared a critical incident after its Nervecentre EPR go-live; technical problems caused long periods of downtime amid high demand. The trust apologised and said it was working with Nervecentre to fix performance issues.
Cyber & information governance
No data breaches, cyber incidents or regulator action involving Nervecentre found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
No product recalls, safety notices or coroners' reports involving Nervecentre found in HSH's search of the last 24 months; see Adverse media for the Nottingham go-live incident.
Contract performance
Mar 2026: York and Scarborough paused its Nervecentre EPR go-live to focus on post-winter recovery, with no new date set. Nottingham's EPR was reported fully working by Feb 2026 after its Nov 2025 issues; Leicester deployed Nervecentre PAS in Nov 2025.
Competitors
No competitors linked yet.